MICHAEL SPERLING: Open Payments
NPI 1518222108 · GALLOWAY, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$428 in 24 payments from 11 companies in 2025. Trend: 2023 $25 · 2024 $0 · 2025 $428
Food & beverage: $428
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 6 | $107 |
| Novo Nordisk Inc | 4 | $84 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $42 |
| AstraZeneca Pharmaceuticals LP | 2 | $36 |
| ABBVIE INC. | 2 | $35 |
| Evofem Biosciences, Inc. | 2 | $33 |
| Exact Sciences Corporation | 1 | $23 |
| Medtronic, Inc. | 1 | $20 |
| Kowa Pharmaceuticals America, Inc. | 1 | $17 |
| PFIZER INC. | 1 | $16 |
Products named: XIFAXAN, Ozempic, JARDIANCE, AIRSUPRA, VRAYLAR, Phexxi, Cologuard Collection Kit, CLOSUREFAST.
Industry payments across NJ — which companies pay providers there.
